English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/144437
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Use of acepromazine for stress control in Spanish ibex (Capra pyrenaica) captured by drive-net

AuthorsCasas-Díaz, Encarna; Marco, Ignasi; López-Olvera, Jorge R. ; Mentaberre, Gregorio
KeywordsAcepromazine
Capra pyrenaica
Drive-net
Spanish ibex
Stress
Issue Date2010
PublisherElsevier
CitationVeterinary Journal 183(3): 332-336 (2010)
AbstractCapture and restraint can induce stress in wild animals and tranquilizers may be beneficial in preventing some of the more adverse effects. A short-acting neuroleptic agent (acepromazine) was assessed in 25 Spanish ibexes (Capra pyrenaica) captured by drive-net. The animals were divided into a control group (14 ibexes) and a treated group (11 ibexes). Heart rate and rectal temperature, as well as haematological and biochemical parameters, were used to evaluate the effects of tranquilization during 3 h of restraint. A reduction in rectal temperature, red blood cell count, packed cell volume, haemoglobin concentration, white blood cell count, lymphocytes, neutrophils, activities of creatine kinase, aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase, and concentrations of urea, total bilirubin and potassium in the treated group, suggested that acepromazine decreased signs of stress in Spanish ibex following drive-net capture.
URIhttp://hdl.handle.net/10261/144437
DOI10.1016/j.tvjl.2008.11.003
Identifiersdoi: 10.1016/j.tvjl.2008.11.003
issn: 1090-0233
e-issn: 1532-2971
Appears in Collections:(IREC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.